vs
德康医疗（DXCM）与Rivian Automotive, Inc.（RIVN）财务数据对比。点击上方公司名可切换其他公司
Rivian Automotive, Inc.的季度营收约是德康医疗的1.0倍（$1.3B vs $1.3B），德康医疗净利率更高（21.2% vs -63.1%，领先84.3%），德康医疗同比增速更快（21.6% vs -25.8%），过去两年德康医疗的营收复合增速更高（12.0% vs 3.3%）
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
Rivian Automotive是2009年成立的美国电动汽车制造商及汽车科技企业，主打基于自研滑板平台打造的电动SUV、皮卡及EDV电动配送货车，旗下R1T皮卡于2021年末正式开启交付，还计划于2023年底前在美国和加拿大布局专属充电网络，其平台可适配新车型也可对外授权使用。
DXCM vs RIVN — 直观对比
营收规模更大
RIVN
是对方的1.0倍
$1.3B
营收增速更快
DXCM
高出47.4%
-25.8%
净利率更高
DXCM
高出84.3%
-63.1%
两年增速更快
DXCM
近两年复合增速
3.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $1.3B |
| 净利润 | $267.3M | $-811.0M |
| 毛利率 | 62.9% | 9.3% |
| 营业利润率 | 25.6% | -64.8% |
| 净利率 | 21.2% | -63.1% |
| 营收同比 | 21.6% | -25.8% |
| 净利润同比 | 153.6% | -9.0% |
| 每股收益（稀释后） | $0.67 | $-0.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXCMRIVN
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.3B | ||
| Q3 25 | $1.2B | $1.6B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $1.0B | $1.2B | ||
| Q4 24 | $1.1B | $1.7B | ||
| Q3 24 | $994.2M | $874.0M | ||
| Q2 24 | $1.0B | $1.2B |
净利润DXCMRIVN
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $-811.0M | ||
| Q3 25 | $283.8M | $-1.2B | ||
| Q2 25 | $179.8M | $-1.1B | ||
| Q1 25 | $105.4M | $-545.0M | ||
| Q4 24 | $151.7M | $-744.0M | ||
| Q3 24 | $134.6M | $-1.1B | ||
| Q2 24 | $143.5M | $-1.5B |
毛利率DXCMRIVN
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 9.3% | ||
| Q3 25 | 60.5% | 1.5% | ||
| Q2 25 | 59.5% | -15.8% | ||
| Q1 25 | 56.9% | 16.6% | ||
| Q4 24 | 58.9% | 9.8% | ||
| Q3 24 | 59.7% | -44.9% | ||
| Q2 24 | 62.4% | -38.9% |
营业利润率DXCMRIVN
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | -64.8% | ||
| Q3 25 | 20.1% | -63.1% | ||
| Q2 25 | 18.4% | -85.5% | ||
| Q1 25 | 12.9% | -52.8% | ||
| Q4 24 | 17.0% | -38.1% | ||
| Q3 24 | 15.3% | -133.8% | ||
| Q2 24 | 15.7% | -118.7% |
净利率DXCMRIVN
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | -63.1% | ||
| Q3 25 | 23.5% | -75.3% | ||
| Q2 25 | 15.5% | -85.7% | ||
| Q1 25 | 10.2% | -44.0% | ||
| Q4 24 | 13.6% | -42.9% | ||
| Q3 24 | 13.5% | -125.9% | ||
| Q2 24 | 14.3% | -125.8% |
每股收益（稀释后）DXCMRIVN
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $-0.66 | ||
| Q3 25 | $0.70 | $-0.96 | ||
| Q2 25 | $0.45 | $-0.97 | ||
| Q1 25 | $0.27 | $-0.48 | ||
| Q4 24 | $0.37 | $-0.67 | ||
| Q3 24 | $0.34 | $-1.08 | ||
| Q2 24 | $0.35 | $-1.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $917.7M | $6.1B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.7B | $4.6B |
| 总资产 | $6.3B | $14.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DXCMRIVN
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $6.1B | ||
| Q3 25 | $1.8B | $7.1B | ||
| Q2 25 | $1.2B | $7.5B | ||
| Q1 25 | $904.9M | $7.2B | ||
| Q4 24 | $606.1M | $7.7B | ||
| Q3 24 | $621.2M | $6.7B | ||
| Q2 24 | $939.2M | $7.9B |
总债务DXCMRIVN
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $5.5B |
股东权益DXCMRIVN
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $4.6B | ||
| Q3 25 | $2.7B | $5.1B | ||
| Q2 25 | $2.6B | $6.1B | ||
| Q1 25 | $2.3B | $6.2B | ||
| Q4 24 | $2.1B | $6.6B | ||
| Q3 24 | $2.0B | $5.9B | ||
| Q2 24 | $2.4B | $6.8B |
总资产DXCMRIVN
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $14.9B | ||
| Q3 25 | $7.5B | $15.2B | ||
| Q2 25 | $7.3B | $15.6B | ||
| Q1 25 | $6.8B | $15.5B | ||
| Q4 24 | $6.5B | $15.4B | ||
| Q3 24 | $6.4B | $14.3B | ||
| Q2 24 | $6.8B | $15.4B |
负债/权益比DXCMRIVN
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.81× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-681.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-1.1B |
| 自由现金流率自由现金流/营收 | — | -89.0% |
| 资本支出强度资本支出/营收 | — | 36.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-2.5B |
8季度趋势，按日历期对齐
经营现金流DXCMRIVN
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $-681.0M | ||
| Q3 25 | $659.9M | $26.0M | ||
| Q2 25 | $303.0M | $64.0M | ||
| Q1 25 | $183.8M | $-188.0M | ||
| Q4 24 | $301.4M | $1.2B | ||
| Q3 24 | $199.5M | $-876.0M | ||
| Q2 24 | $279.4M | $-754.0M |
自由现金流DXCMRIVN
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $-1.1B | ||
| Q3 25 | $579.4M | $-421.0M | ||
| Q2 25 | $208.9M | $-398.0M | ||
| Q1 25 | $96.8M | $-526.0M | ||
| Q4 24 | $176.8M | $856.0M | ||
| Q3 24 | $88.3M | $-1.2B | ||
| Q2 24 | $213.3M | $-1.0B |
自由现金流率DXCMRIVN
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | -89.0% | ||
| Q3 25 | 47.9% | -27.0% | ||
| Q2 25 | 18.1% | -30.5% | ||
| Q1 25 | 9.3% | -42.4% | ||
| Q4 24 | 15.9% | 49.4% | ||
| Q3 24 | 8.9% | -131.9% | ||
| Q2 24 | 21.2% | -89.6% |
资本支出强度DXCMRIVN
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 36.0% | ||
| Q3 25 | 6.7% | 28.7% | ||
| Q2 25 | 8.1% | 35.5% | ||
| Q1 25 | 8.4% | 27.3% | ||
| Q4 24 | 11.2% | 18.9% | ||
| Q3 24 | 11.2% | 31.7% | ||
| Q2 24 | 6.6% | 24.4% |
现金转化率DXCMRIVN
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | — | ||
| Q3 25 | 2.33× | — | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 1.74× | — | ||
| Q4 24 | 1.99× | — | ||
| Q3 24 | 1.48× | — | ||
| Q2 24 | 1.95× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DXCM
暂无分部数据
RIVN
| Automotive Segment | $839.0M | 65% |
| Software And Services Segment | $447.0M | 35% |
| Regulatory Credits | $30.0M | 2% |
